First Wave BioPharma Announces Results of Special Meeting of Stockholders

January 13, 2023

https://www.globenewswire.com/news-release/2023/01/13/2588687/0/en/First-Wave-BioPharma-Announces-Results-of-Special-Meeting-of-Stockholders.html

BOCA RATON, Fla., Jan. 13, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that the Company’s stockholders have approved all proposals voted on at the Company’s special meeting of stockholders (the “Special Meeting”) held on January 13, 2023.

Read more at globenewswire.com

Related news for (FWBI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.